Table 2. Biomarkers, EBV-DNA quantification and TCR-rearrangement status of EBV + NK/T-lymphoma patients.

Case	Histology	cCD3	CD4	CD8	CD56	TCRb/TCRg	TIA	GranB	Ki-67 (%)	HLA-DR	EBER	TCR-rearrangement	EBV-DNA (copies/mL)
1	STCLC	+	+	+	−	+	N	N	N	+	N	+	1.58E+5
2	STCLC	+	+	−	−	+	+	+	50	N	+	+	2.27E+5
3	STCLC	+	+	+	−	+	+	+	40	N	+	+	2.87E+5
4	STCLC	+	+	+	−	+	N	N	N	+	N	+	5.74E+5
5	STCLC	+	−	+	−	+	+	+	60	N	N	+	2.99E+5
6	STCLC	+	+	+	−	+	−	+	70	N	+	+	5.43E+3
7	ENKTL	+	+	+	+	+	+	+	60	N	+	+	2.65E+5
8	NNKTL	+	−	+	+	−	+	+	80	N	+	+	1.73E+4

EBV, Epstein-Barr virus; TCR, T cell receptor; NK, natural killer; CD, cluster of differentiation; TIA, T-cell intracellular antigen; HLA-DR, human leukocyte antigen-DR isotype; EBER, EBV-encoded RNA; STCLC, systemic EBV+ T-cell lymphoma of childhood; N, not done; +, positive; −, negative; ENKTL, extranodal NK/T-cell lymphoma, nasal-type; NNKTL, nodal T/NK-cell lymphoma.